• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

Recent Advances in the Application of Ethyl 3-amino-4-cyanothiophene-2-carboxylate (CAS: 102123-27-3) in Chemical Biology and Pharmaceutical Research

Ethyl 3-amino-4-cyanothiophene-2-carboxylate (CAS: 102123-27-3) is a versatile heterocyclic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its thiophene core and functionalized with amino, cyano, and ester groups, serves as a key intermediate in the synthesis of various bioactive molecules. Recent studies have explored its utility in drug discovery, particularly in the development of kinase inhibitors, antimicrobial agents, and fluorescent probes for biological imaging.

One of the most notable advancements involves the use of ethyl 3-amino-4-cyanothiophene-2-carboxylate as a building block for the synthesis of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its incorporation into a series of compounds targeting the epidermal growth factor receptor (EGFR), a critical player in cancer progression. The researchers reported that derivatives of this compound exhibited potent inhibitory activity against EGFR mutants, with IC50 values in the low nanomolar range. These findings highlight the compound's potential in addressing drug-resistant forms of cancer.

In addition to its role in kinase inhibitor development, ethyl 3-amino-4-cyanothiophene-2-carboxylate has shown promise in antimicrobial research. A recent study in Bioorganic & Medicinal Chemistry Letters described its use in the synthesis of thiophene-based analogs with broad-spectrum antibacterial activity. The researchers found that certain derivatives displayed significant efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli, suggesting potential applications in combating antibiotic-resistant infections.

The compound's unique photophysical properties have also been exploited in the design of fluorescent probes for biological imaging. A 2022 publication in Analytical Chemistry detailed the development of a thiophene-based fluorescent sensor derived from ethyl 3-amino-4-cyanothiophene-2-carboxylate, capable of selectively detecting reactive oxygen species (ROS) in live cells. This probe exhibited high sensitivity and stability, making it a valuable tool for studying oxidative stress in biological systems.

From a synthetic chemistry perspective, recent work has focused on optimizing the preparation of ethyl 3-amino-4-cyanothiophene-2-carboxylate and its derivatives. A 2023 paper in Organic Process Research & Development reported an improved, scalable synthesis route with higher yields and reduced environmental impact. The authors emphasized the importance of this advancement for enabling larger-scale production of the compound for pharmaceutical applications.

Looking ahead, researchers are exploring the potential of ethyl 3-amino-4-cyanothiophene-2-carboxylate in additional therapeutic areas, including neurodegenerative diseases and inflammatory disorders. Preliminary studies suggest that its derivatives may modulate key pathways involved in these conditions, though further investigation is needed to fully elucidate their mechanisms of action and therapeutic potential.

In conclusion, ethyl 3-amino-4-cyanothiophene-2-carboxylate (CAS: 102123-27-3) continues to emerge as a valuable scaffold in chemical biology and pharmaceutical research. Its diverse applications, ranging from drug discovery to biological imaging, underscore its importance in advancing biomedical science. Ongoing research efforts are expected to further expand its utility and lead to the development of novel therapeutic agents and research tools in the coming years.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)